Albin Simoni is an experienced senior process engineer specializing in Drug Substance processing, currently serving as Program Lead at Merck Group since 2025. Albin previously held the role of Head of Global MSAT DS, where they led the Community of Experts for biotechnology drug substance networks and managed major change controls. With a robust background that includes positions at Novartis and Glenmark Pharmaceuticals, Albin has contributed significantly to downstream processing and purification processes, demonstrating expertise in technical leadership and project management within the biotech industry. Albin's educational credentials span multiple degrees in biotechnology and life sciences, underscoring a solid foundation for their innovative work in biotech manufacturing.
This person is not in the org chart
This person is not in any teams
This person is not in any offices